DNA Insider Trading

Insider Ownership Percentage: 9.72%
Insider Buying (Last 12 Months): $270,833.29
Insider Selling (Last 12 Months): $294,547.04

Ginkgo Bioworks Insider Trading History Chart

This chart shows the insider buying and selling history at Ginkgo Bioworks by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

Ginkgo Bioworks Share Price & Price History

Current Price: $8.11
Price Change: Price Increase of +0.813 (11.14%)
As of 04/11/2025 04:59 PM ET

This chart shows the closing price history over time for DNA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$8.11Closing price on 04/11/25:

SEC Filings (Institutional Ownership Changes) for Ginkgo Bioworks (NYSE:DNA)

78.63% of Ginkgo Bioworks stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DNA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$36kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2B-$1B$0$1B$2BTotal InflowsTotal Outflows
Ginkgo Bioworks logo
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Read More on Ginkgo Bioworks

Today's Range

Now: $8.11
Low: $7.25
High: $8.40

50 Day Range

MA: $8.83
Low: $5.54
High: $16.38

52 Week Range

Now: $8.11
Low: $5.00
High: $45.20

Volume

3,131,985 shs

Average Volume

1,489,264 shs

Market Capitalization

$470.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Ginkgo Bioworks?

Ginkgo Bioworks' top insider investors include:
  1. Reshma P Shetty (Insider)
  2. Barry Canton (Major Shareholder)
  3. Jason R Kelly (Insider)
  4. Marijn E Dekkers (Director)
  5. Shyam Sankar (Director)
  6. Christian O Henry (Director)
  7. Mark E Dmytruk (Insider)
  8. Harry Sloan (Director)
  9. Steven P Coen (Insider)
  10. Marie E Fallon (Insider)
Learn More about top insider investors at Ginkgo Bioworks.

Who are the major institutional investors of Ginkgo Bioworks?

Ginkgo Bioworks' top institutional investors include:
  1. Green Alpha Advisors LLC — 0.03%
Learn More about top institutional investors of Ginkgo Bioworks stock.

Which institutional investors are buying Ginkgo Bioworks stock?

In the last quarter, DNA stock was purchased by institutional investors including:
  1. Green Alpha Advisors LLC
During the last year, these company insiders have bought Ginkgo Bioworks stock:
  1. Reshma P Shetty (Insider)
  2. Barry Canton (Major Shareholder)
Learn More investors buying Ginkgo Bioworks stock.